SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-005558
Filing Date
2021-11-29
Accepted
2021-11-29 21:23:48
Documents
2
Period of Report
2021-11-18

Document Format Files

Seq Description Document Type Size
1 form3-11292021_061138.html 3  
1 form3-11292021_061138.xml 3 5708
2 ex24-11292021_061139.htm EX-24 8409
  Complete submission text file 0001415889-21-005558.txt   15601
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address
Ni Fang (Reporting) CIK: 0001895910 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 211458138